Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Brezofree 250 Synchrobreathe SB - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Brezofree 250 Synchrobreathe SB

Approved

STANDARD

Brezofree 250 Synchrobreathe SB

Cipla Limited (Unit II)🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 5703a1f22a005381
Company: Cipla Limited (Unit II)
Type: Standard

Approval Details

Approval Id: 5703a1f22a005381
Drug Approval Philippines Name: Brezofree 250 Synchrobreathe SB
Product Name: Brezofree 250 Synchrobreathe SB
Registration Number: DRP-11324
Brand Name: Brezofree 250 Synchrobreathe SB
Generic Name: Salmeterol (as xinafoate) + Fluticasone Propionate
Dosage Form: Metered Dose Inhaler (Suspension)
Dosage Strength: 25 mcg/250 mcg
Manufacturer: Cipla Limited (Unit II)
Importer: RV Group Phil. Branch
Distributor: RV Group Phil. Branch
Issuance Date: 24 June 2024
Expiry Date: 02 March 2027
Pharmacologic Category: Anti-asthma (Adrenergic/Corticosteriod)
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

5703a1f22a005381

Type

Standard

Back to Philippines FDA Approvals